Background: Esophageal squamous cell carcinoma is a relative common malignancy with a very poor prognosis, even adopting an integrated and multidisciplinary approach. According to the literature, gastrointestinal stromal tumors (GISTs) rarely originate from the esophagus. Moreover there are not reports of synchronous occurrence of squamous cell carcinoma and GIST at esophageal site.
Our group recently described a 23-week fetus with the association of holoprosencephaly-diencephalic hamortoblastoma (HDH) and reviewed the literature, identifying 19 additional patients with similar features. Both clinical and etiological heterogeneity were outlined, thus suggesting that HDH could indeed represent an overlapping phenotype of separate conditions, perhaps within a common morphogenetic pathway. In pathogenetic perspective, we hypothesized that the cause(s) for HDH may act early in gestation, probably during blastogenesis [Castori et al., 2007].We had an opportunity to evaluate an additional fetus with HDH, born to a G1P0 36-year-old woman and a 33-year-old man. Family history was unremarkable. Following ultrasound detection of alobar holoprosencephaly (HPE) and severe IUGR, transabdominal amniocentesis performed at 17 weeks demonstrated a 69,XXX fetal karyotype. Pregnancy was terminated at 19 weeks. Physical examination showed a female fetus with a weight of 108 g (<3rd centile); crown-rump length, 13 cm; crown-heel length, 19 cm (<3rd centile); and head circumference, 13 cm (<3rd centile), suggestive of apparently symmetric growth restriction. Facial abnormalities included upslanting palpebral fissures, apparently low-set ears, premaxillary agenesis, ankyloglossia, retrognathia, and mild nuchal edema (Fig. 1A,B). Bilateral III-IV finger and II-V toe syndactyly, stubby great toe on the left, and sandal gap of the right foot were also evident ( Fig. 1C-E). Necropsy findings comprised ostium secundum type interatrial septal defect, ventricular septal defect, ''horseshoe'' kidneys with cystic dysplastic disease of the fused inferior poles, and hypoplastic adrenal glands. The placenta was small (29 g, <3rd centile) with multiple calcifications and had no sign of hydatiform degeneration. Brain dissection showed alobar HPE with a single ventricle and the absence of the falx cerebri, corpus callosum, septum pellucidum, and olfactory tracts and bulbs. Both thalami were substituted by a mass extending over the optic chiasm and the right optic nerve (Fig. 2A). Microscopically, this mass was composed of disorganized relatively mature neurons, glial cells, ependymal elements, and vessels, without any cytological atypia (Fig. 2B,C). These findings were consistent with hypothalamic hamartoma (HH). The eyes were normally formed and histologic examination showed bilateral retinal dysplasia, manifested by numerous rosettes and minimal gliosis (Fig. 2D). Neuronal migration defects and other histological abnormalities were excluded. A radiographic survey confirmed limb anomalies and
Objectives: The discovery of tyrosine kinase inhibitors (TKI) has remarkably improved the clinical course of patients with non–small cell lung cancer driven by Epidermal Growth Factor Receptor (EGFR) mutations. However, virtually in all cases, the disease resurfaces in a TKI-resistant form that is mainly linked to an acquired EGFR-T790M mutation, a MET amplification, or small cell lung cancer (SCLC) transformation. Third-generation TKIs are able to block tumor growth through an irreversible binding to the T790M-mutated receptor. Such new treatments require the diagnostic analysis of new pathologic tissue or a liquid biopsy to detect the presence of the T790M mutation. Materials and Methods: Pre-TKI and post-TKI biopsies from 27 patients with an activating EGFR mutation were collected and analyzed for EGFR-T790M mutation, MET amplification, and SCLC transformation. Results: The T790M mutation was found in 16 patients (59%) whereas MET gene amplification was found in 2 (10.5%) of 19 evaluated cases. The histologic transformation from adenocarcinoma (ADC) to SCLC was identified in 3 patients (11%). In one of them reversal from SCLC back to adenocarcinoma was observed. One patient had the T790M mutation concordantly detected in 2 synchronous lesions whereas another patient showed T790M positivity only in one of 2 specimens. In 4 patients longitudinal biopsies revealed T790M gains and losses not always according to biological expectations. Conclusions: Intrapatient molecular or histologic heterogeneity may be frequently found during routine treatment of non–small cell lung cancer patients. This biological aspect may have profound repercussions on subsequent therapeutic decisions, and therefore requires in-depth investigation.
AimsDiagnostic tumour samples are mandatory for morphologic and molecular diagnosis of non-small cell lung cancer (NSCLC) to establish the best therapeutic approach. In the presence of small tumour tissue sample, the pathologist needs to make responsible choices to achieve a correct diagnosis and save material for subsequent molecular evaluations. Nevertheless, in some instances, the diagnostic process can lead to tissue depletion. The automated Idylla epidermal growth factor receptor (EGFR) mutation test has been developed to rapidly process formalin-fixed paraffin-embedded (FFPE) pathologic material, without previous DNA extraction. This study aimed to test whether this platform is suitable for the reuse of H&E, immunohistochemistry (IHC) and fluorescence in situ hybridisation (FISH) diagnostic slides.MethodsA training set of 19 FFPE tissues with known EGFR status was revaluated on H&E slides. Fourteen of them were also tested using IHC and FISH treated specimens. An additional series of 25 H&E, IHC or FISH slides of NSCLC cases tested for EGFR mutation at an external institution was blindly assessed as a validation cohort.ResultsCombining the two sets, 32 of 32 classical ex19dels and p.L858R were correctly identified. Three uncommon mutations (p.G719X, p.L861Q and ex20ins) were also detected. Four discrepancies were related to rare ex19del/ins not included in the Idylla list of detectable mutations. Two p.T790M variants were missed on one FFPE and two H&E slides but were detected using IHC and FISH sections from the same FFPE blocks.ConclusionsThe Idylla EGFR mutation test is highly reliable using differently treated tumour specimens and should be validated in larger studies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.